Difference between revisions of "GTS5:Volunteer Assignments and Opportunities"
Jump to navigation
Jump to search
[checked revision] | [checked revision] |
Line 420: | Line 420: | ||
|[[GTS5:Neurofibromatosis_type_1_(NF1)|Neurofibromatosis type 1 (NF1)]] | |[[GTS5:Neurofibromatosis_type_1_(NF1)|Neurofibromatosis type 1 (NF1)]] | ||
|Disease | |Disease | ||
+ | |Ngoni Faya (trainee) + Madina Sukhanova | ||
+ | |7/12/2023 | ||
| | | | ||
+ | |PENDING | ||
| | | | ||
+ | |Madina Sukhanova (Madina S) | ||
| | | | ||
− | | | + | |Named based on GTS5 book |
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|[[GTS5:NF2-related_schwannomatosis_(NF2)|NF2-related schwannomatosis (NF2)]] | |[[GTS5:NF2-related_schwannomatosis_(NF2)|NF2-related schwannomatosis (NF2)]] | ||
Line 497: | Line 497: | ||
|[[GTS5:Familial_adenomatous_polyposis_(APC)|Familial adenomatous polyposis (APC)]] | |[[GTS5:Familial_adenomatous_polyposis_(APC)|Familial adenomatous polyposis (APC)]] | ||
|Disease | |Disease | ||
+ | |Jennifer Laffin | ||
+ | |8/20/2023 | ||
| | | | ||
+ | |PENDING | ||
| | | | ||
+ | |MS / LS | ||
| | | | ||
− | | | + | |Named based on GTS5 book |
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|[[GTS5:Gastric_Adenocarcinoma_and_Proximal_Polyposis_of_Stomach_-_GAPPS_(APC_promoter)|Gastric Adenocarcinoma and Proximal Polyposis of Stomach - GAPPS (APC promoter)]] | |[[GTS5:Gastric_Adenocarcinoma_and_Proximal_Polyposis_of_Stomach_-_GAPPS_(APC_promoter)|Gastric Adenocarcinoma and Proximal Polyposis of Stomach - GAPPS (APC promoter)]] | ||
Line 581: | Line 581: | ||
| | | | ||
| | | | ||
− | | | + | |Named based on GTS5 book (page created 12/30/23) |
|- | |- | ||
|[[GTS5:Hereditary_gastric_and_breast_cancer_syndrome_(CDH1,_CTNNA1)|Hereditary gastric and breast cancer syndrome (CDH1, CTNNA1)]] | |[[GTS5:Hereditary_gastric_and_breast_cancer_syndrome_(CDH1,_CTNNA1)|Hereditary gastric and breast cancer syndrome (CDH1, CTNNA1)]] | ||
Line 592: | Line 592: | ||
| | | | ||
| | | | ||
− | | | + | |Named based on GTS5 book (page created 12/30/23) |
|- | |- | ||
|[[GTS5:Hereditary_mixed_polyposis_syndrome_(GREM1)|Hereditary mixed polyposis syndrome (GREM1)]] | |[[GTS5:Hereditary_mixed_polyposis_syndrome_(GREM1)|Hereditary mixed polyposis syndrome (GREM1)]] | ||
Line 841: | Line 841: | ||
| | | | ||
| | | | ||
− | | | + | |Named based on GTS5 book (page created 12/30/23) |
|- | |- | ||
|[[GTS5:Retinoblastoma_syndrome_(RB1)|Retinoblastoma syndrome (RB1)]] | |[[GTS5:Retinoblastoma_syndrome_(RB1)|Retinoblastoma syndrome (RB1)]] | ||
Line 942: | Line 942: | ||
|[[GTS5:Constitutional_mismatch_repair_deficiency_(CMMRD)_syndrome_(MLH1,_PMS2,_MSH2,_MSH6)|Constitutional mismatch repair deficiency (CMMRD) syndrome (MLH1, PMS2, MSH2, MSH6)]] | |[[GTS5:Constitutional_mismatch_repair_deficiency_(CMMRD)_syndrome_(MLH1,_PMS2,_MSH2,_MSH6)|Constitutional mismatch repair deficiency (CMMRD) syndrome (MLH1, PMS2, MSH2, MSH6)]] | ||
|Disease | |Disease | ||
+ | |Jennie Thurston | ||
+ | |7/2/2023 | ||
| | | | ||
+ | |PENDING | ||
| | | | ||
+ | |LS | ||
| | | | ||
− | | | + | |Named based on GTS5 book |
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|[[GTS5:BRCA-related_cancer_predisposition_syndrome_(BRCA1,_BRCA2)|BRCA-related cancer predisposition syndrome (BRCA1, BRCA2)]] | |[[GTS5:BRCA-related_cancer_predisposition_syndrome_(BRCA1,_BRCA2)|BRCA-related cancer predisposition syndrome (BRCA1, BRCA2)]] | ||
|Disease | |Disease | ||
+ | |Constance Albarracin / Katherine Geiersbach | ||
| | | | ||
| | | | ||
+ | |PENDING | ||
| | | | ||
+ | |Katherine Geiersbach | ||
| | | | ||
− | | | + | |Named based on GTS5 book (page created 12/30/23) |
− | |||
− | |||
− | |||
|- | |- | ||
|[[GTS5:PALB2-related_cancer_predisposition_syndrome_(PALB2)|PALB2-related cancer predisposition syndrome (PALB2)]] | |[[GTS5:PALB2-related_cancer_predisposition_syndrome_(PALB2)|PALB2-related cancer predisposition syndrome (PALB2)]] | ||
|Disease | |Disease | ||
+ | |Constance Albarracin / Katherine Geiersbach / Jun Liao | ||
| | | | ||
| | | | ||
+ | |PENDING | ||
| | | | ||
+ | |Katherine Geiersbach | ||
| | | | ||
− | | | + | |Named based on GTS5 book (page created 12/30/23) |
− | |||
− | |||
− | |||
|- | |- | ||
|[[GTS5:RAD51-related_cancer_predisposition_syndrome_(RAD51C,_RAD51D)|RAD51-related cancer predisposition syndrome (RAD51C, RAD51D)]] | |[[GTS5:RAD51-related_cancer_predisposition_syndrome_(RAD51C,_RAD51D)|RAD51-related cancer predisposition syndrome (RAD51C, RAD51D)]] | ||
Line 1,041: | Line 1,041: | ||
|[[GTS5:Ataxia-telangiectasia_syndrome_(ATM)|Ataxia-telangiectasia syndrome (ATM)]] | |[[GTS5:Ataxia-telangiectasia_syndrome_(ATM)|Ataxia-telangiectasia syndrome (ATM)]] | ||
|Disease | |Disease | ||
+ | |Evin Gulbahce / Katherine Geiersbach | ||
| | | | ||
| | | | ||
+ | |PENDING | ||
| | | | ||
+ | |Katherine Geiersbach | ||
| | | | ||
− | | | + | |Named based on GTS5 book (page created 12/30/23) |
− | |||
− | |||
− | |||
|- | |- | ||
|[[GTS5:CHEK2-related_hereditary_(breast)_cancer_predisposition_syndrome_(CHEK2)|CHEK2-related hereditary (breast) cancer predisposition syndrome (CHEK2)]] | |[[GTS5:CHEK2-related_hereditary_(breast)_cancer_predisposition_syndrome_(CHEK2)|CHEK2-related hereditary (breast) cancer predisposition syndrome (CHEK2)]] | ||
Line 1,059: | Line 1,059: | ||
| | | | ||
| | | | ||
− | | | + | |Named based on GTS5 book (page created 12/30/23) |
|- | |- | ||
|[[GTS5:Nijmegen_breakage_syndrome_(NBN)|Nijmegen breakage syndrome (NBN)]] | |[[GTS5:Nijmegen_breakage_syndrome_(NBN)|Nijmegen breakage syndrome (NBN)]] | ||
Line 1,321: | Line 1,321: | ||
|[[GTS5:DICER1-related_tumour_predisposition_syndrome_(DICER1)|DICER1-related tumour predisposition syndrome (DICER1)]] | |[[GTS5:DICER1-related_tumour_predisposition_syndrome_(DICER1)|DICER1-related tumour predisposition syndrome (DICER1)]] | ||
|Disease | |Disease | ||
+ | |Jennie Thurston | ||
+ | |7/2/2023 | ||
| | | | ||
+ | |PENDING | ||
| | | | ||
+ | |LS | ||
| | | | ||
− | | | + | |Named based on GTS5 book |
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|[[GTS5:MicroRNA_processor_tumour_predisposition_syndromes_(DROSHA,_DGCR8)|MicroRNA processor tumour predisposition syndromes (DROSHA, DGCR8)]] | |[[GTS5:MicroRNA_processor_tumour_predisposition_syndromes_(DROSHA,_DGCR8)|MicroRNA processor tumour predisposition syndromes (DROSHA, DGCR8)]] |
Revision as of 12:27, 25 February 2024
Welcome!
For assignments, please see the "Author" column below (highlighted blue).
If empty (no name is present), please volunteer to create content for that disease!
To volunteer, please [Contact us] with your page of interest.
Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
---|---|---|---|---|---|---|---|---|---|
CHAPTER 2 (GROWTH FACTOR RECEPTORS AND RELATED SIGNALLING PATHWAYS) |
|
|
|
|
|
|
|
|
|
Neurofibromatosis Type 1 (NF1) | Disease | Ngoni Faya (trainee) + Madina Sukhanova | 7/12/2023 | PENDING | Madina Sukhanova (Madina S) | Named based on GTS5 book | |||
Familial Adenomatous Polyposis (APC) | Disease | Jennifer Laffin | 8/20/2023 | PENDING | MS / LS | Named based on GTS5 book | |||
Peutz-Jeghers Syndrome (STK11) | Disease | Named based on GTS5 book (page created 12/30/23) | |||||||
Hereditary Gastric and Breast Cancer Syndrome (CDH1, CTNNA1) | Disease | Named based on GTS5 book (page created 12/30/23) | |||||||
CHAPTER 3 (OXIDATIVE STRESS RESPONSE AND METABOLISM) |
|
|
|
|
|
|
|
|
|
CHAPTER 4 (CELL CYCLE AND APOPTOSIS PATHWAYS) |
|
|
|
|
|
|
|
|
|
Li-Fraumeni Syndrome (TP53) | Disease | Named based on GTS5 book (page created 12/30/23) | |||||||
CHAPTER 5 (DNA REPAIR AND GENOMIC STABILITY) |
|
|
|
|
|
|
|
|
|
Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6) | Disease | Jennie Thurston | 7/2/2023 | PENDING | LS | Named based on GTS5 book | |||
BRCA-Related Cancer Predisposition Syndrome (BRCA1, BRCA2) | Disease | Constance Albarracin / Katherine Geiersbach | PENDING | Katherine Geiersbach | Named based on GTS5 book (page created 12/30/23) | ||||
PALB2-Related Cancer Predisposition Syndrome (PALB2) | Disease | Constance Albarracin / Katherine Geiersbach / Jun Liao | PENDING | Katherine Geiersbach | Named based on GTS5 book (page created 12/30/23) | ||||
Ataxia-Telangiectasia Syndrome (ATM) | Disease | Evin Gulbahce / Katherine Geiersbach | PENDING | Katherine Geiersbach | Named based on GTS5 book (page created 12/30/23) | ||||
CHEK2-Related Hereditary (Breast) Cancer Predisposition Syndrome (CHEK2) | Disease | Named based on GTS5 book (page created 12/30/23) | |||||||
CHAPTER 6 (TELOMERE MAINTENANCE) |
|
|
|
|
|
|
|
|
|
CHAPTER 7 (EPIGENETIC DRIVERS AND CHROMATIN REMODELLING) |
|
|
|
|
|
|
|
|
|
CHAPTER 8 (RNA REGULATION) |
|
|
|
|
|
|
|
|
|
DICER1-Related Tumour Predisposition Syndrome (DICER1) | Disease | Jennie Thurston | 7/2/2023 | PENDING | LS | Named based on GTS5 book | |||
CHAPTER 9 (PROTEIN REGULATION) |
|
|
|
|
|
|
|
|
|